Filed: 2/17/2026ACC: 0000921895-26-000449
📋 What this filing means
BVF INC/IL filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $2.97B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$2.97B
Total AUM (reported)
198.88M
Total Shares
Allocation by class
COM$1.99B67.0%
SPONSORED ADS$310.48M10.5%
CLASS A ORD$260.32M8.8%
COM NEW$172.50M5.8%
ORDINARY SHARES$112.11M3.8%
SHS$62.24M2.1%
ADS$59.31M2.0%
Portfolio Concentration
Top 3$955.86M32.2%
4–10$909.52M30.6%
11–25$888.25M29.9%
Rest$217.09M7.3%
Top 3 weight
32.2%
Top 10 weight
62.8%
Voting Authority Distribution
Total shares with voting rights: 198.84M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
198.84M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other41
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings41
Rows:
KYMERA THERAPEUTICS INC
DFNDShares5.50M
TypeSH
Market value$428.17M
14.41%
Sole
0.00
Shared
5.50M
None
0.00
REVOLUTION MEDICINES INC
DFNDShares3.36M
TypeSH
Market value$267.37M
9.00%
Sole
0.00
Shared
3.36M
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares19.75M
TypeSH
Market value$260.32M
8.76%
Sole
0.00
Shared
19.75M
None
0.00
STRUCTURE THERAPEUTICS INC
DFNDShares3.48M
TypeSH
Market value$241.97M
8.15%
Sole
0.00
Shared
3.48M
None
0.00
OLEMA PHARMACEUTICALS INC
DFNDShares5.30M
TypeSH
Market value$132.40M
4.46%
Sole
0.00
Shared
5.30M
None
0.00
MIRUM PHARMACEUTICALS INC
DFNDShares1.50M
TypeSH
Market value$118.11M
3.98%
Sole
0.00
Shared
1.50M
None
0.00
GH RESEARCH PLC
DFNDShares8.83M
TypeSH
Market value$112.11M
3.77%
Sole
0.00
Shared
8.83M
None
0.00
XENCOR INC
DFNDShares7.13M
TypeSH
Market value$109.22M
3.68%
Sole
0.00
Shared
7.13M
None
0.00
ZYMEWORKS INC
DFNDShares3.94M
TypeSH
Market value$103.70M
3.49%
Sole
0.00
Shared
3.94M
None
0.00
PALVELLA THERAPEUTICS INC NE
DFNDShares879.01K
TypeSH
Market value$92.01M
3.10%
Sole
0.00
Shared
879.01K
None
0.00
KURA ONCOLOGY INC
DFNDShares8.62M
TypeSH
Market value$89.53M
3.01%
Sole
0.00
Shared
8.62M
None
0.00
STOKE THERAPEUTICS INC
DFNDShares2.27M
TypeSH
Market value$71.91M
2.42%
Sole
0.00
Shared
2.27M
None
0.00
XOMA ROYALTY CORPORATION
DFNDShares2.59M
TypeSH
Market value$68.88M
2.32%
Sole
0.00
Shared
2.59M
None
0.00
ABIVAX SA
DFNDShares508.03K
TypeSH
Market value$68.51M
2.31%
Sole
0.00
Shared
508.03K
None
0.00
NEKTAR THERAPEUTICS
DFNDShares1.56M
TypeSH
Market value$65.94M
2.22%
Sole
0.00
Shared
1.56M
None
0.00
AC IMMUNE SA
DFNDShares19.82M
TypeSH
Market value$62.24M
2.10%
Sole
0.00
Shared
19.82M
None
0.00
MONTE ROSA THERAPEUTICS INC
DFNDShares3.84M
TypeSH
Market value$60.15M
2.02%
Sole
0.00
Shared
3.84M
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares5.75M
TypeSH
Market value$59.52M
2.00%
Sole
0.00
Shared
5.75M
None
0.00
TYRA BIOSCIENCES INC
DFNDShares2.13M
TypeSH
Market value$55.94M
1.88%
Sole
0.00
Shared
2.13M
None
0.00
DISC MEDICINE INC
DFNDShares650K
TypeSH
Market value$51.62M
1.74%
Sole
0.00
Shared
650K
None
0.00
IMMUNOCORE HLDGS PLC
DFNDShares1.49M
TypeSH
Market value$50.29M
1.69%
Sole
0.00
Shared
1.45M
None
0.00
INVIVYD INC
DFNDShares19.52M
TypeSH
Market value$48.23M
1.62%
Sole
0.00
Shared
19.52M
None
0.00
SEPTERNA INC
DFNDShares1.72M
TypeSH
Market value$47.98M
1.61%
Sole
0.00
Shared
1.72M
None
0.00
ANNEXON INC
DFNDShares9.13M
TypeSH
Market value$45.82M
1.54%
Sole
0.00
Shared
9.13M
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares7.76M
TypeSH
Market value$41.70M
1.40%
Sole
0.00
Shared
7.76M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KYMERA THERAPEUTICS INCDFND | COM | 5.50M | SH | $428.17M 14.41% | 0.00 | 5.50M | 0.00 |
REVOLUTION MEDICINES INCDFND | COM | 3.36M | SH | $267.37M 9.00% | 0.00 | 3.36M | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 19.75M | SH | $260.32M 8.76% | 0.00 | 19.75M | 0.00 |
STRUCTURE THERAPEUTICS INCDFND | SPONSORED ADS | 3.48M | SH | $241.97M 8.15% | 0.00 | 3.48M | 0.00 |
OLEMA PHARMACEUTICALS INCDFND | COM | 5.30M | SH | $132.40M 4.46% | 0.00 | 5.30M | 0.00 |
MIRUM PHARMACEUTICALS INCDFND | COM | 1.50M | SH | $118.11M 3.98% | 0.00 | 1.50M | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 8.83M | SH | $112.11M 3.77% | 0.00 | 8.83M | 0.00 |
XENCOR INCDFND | COM | 7.13M | SH | $109.22M 3.68% | 0.00 | 7.13M | 0.00 |
ZYMEWORKS INCDFND | COM | 3.94M | SH | $103.70M 3.49% | 0.00 | 3.94M | 0.00 |
PALVELLA THERAPEUTICS INC NEDFND | COM | 879.01K | SH | $92.01M 3.10% | 0.00 | 879.01K | 0.00 |
KURA ONCOLOGY INCDFND | COM | 8.62M | SH | $89.53M 3.01% | 0.00 | 8.62M | 0.00 |
STOKE THERAPEUTICS INCDFND | COM | 2.27M | SH | $71.91M 2.42% | 0.00 | 2.27M | 0.00 |
XOMA ROYALTY CORPORATIONDFND | COM NEW | 2.59M | SH | $68.88M 2.32% | 0.00 | 2.59M | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 508.03K | SH | $68.51M 2.31% | 0.00 | 508.03K | 0.00 |
NEKTAR THERAPEUTICSDFND | COM NEW | 1.56M | SH | $65.94M 2.22% | 0.00 | 1.56M | 0.00 |
AC IMMUNE SADFND | SHS | 19.82M | SH | $62.24M 2.10% | 0.00 | 19.82M | 0.00 |
MONTE ROSA THERAPEUTICS INCDFND | COM | 3.84M | SH | $60.15M 2.02% | 0.00 | 3.84M | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 5.75M | SH | $59.52M 2.00% | 0.00 | 5.75M | 0.00 |
TYRA BIOSCIENCES INCDFND | COM | 2.13M | SH | $55.94M 1.88% | 0.00 | 2.13M | 0.00 |
DISC MEDICINE INCDFND | COM | 650K | SH | $51.62M 1.74% | 0.00 | 650K | 0.00 |
IMMUNOCORE HLDGS PLCDFND | ADS | 1.49M | SH | $50.29M 1.69% | 0.00 | 1.45M | 0.00 |
INVIVYD INCDFND | COM | 19.52M | SH | $48.23M 1.62% | 0.00 | 19.52M | 0.00 |
SEPTERNA INCDFND | COM | 1.72M | SH | $47.98M 1.61% | 0.00 | 1.72M | 0.00 |
ANNEXON INCDFND | COM | 9.13M | SH | $45.82M 1.54% | 0.00 | 9.13M | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 7.76M | SH | $41.70M 1.40% | 0.00 | 7.76M | 0.00 |
Page 1 of 2